Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10345530 | Computer Methods and Programs in Biomedicine | 2014 | 11 Pages |
Abstract
One of the major sources of information on physiological and pathophysiological effects in pre-clinical oncology studies is the xenografted tumour animal model. However, measurement of tumour volume over time potentially masks a range of biological changes that the xenograft is undergoing. In this paper a mechanistic model of tumour growth in xenografts is presented that can be used to investigate the mode of drug action with respect to phenotypic changes. The model encapsulates key histological biomarkers and spatial constraints. The unknown model parameters are first shown to be uniquely identifiable from the proposed experimental studies, and then estimated from the resulting data using the anti-cancer agent docetaxel.
Related Topics
Physical Sciences and Engineering
Computer Science
Computer Science (General)
Authors
Neil D. Evans, Richard J. Dimelow, James W.T. Yates,